The Food and Drug Administration has issued an emergency use authorization for a rapid, single-use test to detect Ebola virus. The test is the second Ebola fingerstick test to receive an EUA, but the first to use a portable battery-operated reader. “By authorizing the first fingerstick test with a portable reader, we hope to better arm health care providers in the field to more quickly detect the virus in patients and improve patient outcomes,” said FDA Commissioner Scott Gottlieb, M.D., noting that the agency continues to collaborate with federal, international and industry partners to assist in the global response to the Ebola outbreak in the Democratic Republic of Congo.
 

Related News Articles

Headline
The outbreak of Ebola virus disease in the Democratic Republic of the Congo has become so serious that international public health experts should consider that…
Headline
The World Health Organization said today that the latest outbreak of Ebola virus disease in the Democratic Republic of the Congo does not constitute a global…
Headline
The Senate last night voted 85-7 to pass an $857 billion spending package, which includes bills that would fund the departments of Health and Human Services,…
Headline
Health care and public health professionals can register to attend a Sept. 19-20 workshop in Omaha, Neb., on preparing for emerging infectious diseases, such…
Headline
The Democratic Republic of the Congo yesterday launched an Ebola vaccination campaign for high-risk populations in North Kivu province, where a new outbreak of…
Headline
The Democratic Republic of the Congo has identified a new cluster of presumed Ebola cases based on preliminary laboratory results, the World Health…